Posted by Michael Wonder on 30 Nov 2021
Caldolor now FDA approved for pre-operative administration
29 November 2021 - Dosed prior to surgery, Caldolor demonstrated significant reduction in pain intensity.
Cumberland Pharmaceuticals today announced the U.S. FDA has approved expanded labelling for Caldolor, an intravenously delivered formulation of ibuprofen, to now include use in pre-operative administration.
